Welcome to our dedicated page for Veritone SEC filings (Ticker: VERI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Veritone's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Veritone's regulatory disclosures and financial reporting.
Morales Francisco reported acquisition or exercise transactions in this Form 4 filing.
Veritone, Inc. director Francisco Morales reported two equity compensation awards in the form of restricted stock units. Each award covers 120,000 RSUs, representing future rights to receive common shares at no purchase price.
For one award, all 120,000 RSUs vest on the earlier of July 7, 2027 or the day immediately before Veritone’s 2027 annual stockholder meeting. For the second award, 50% vests on that same 2027 date benchmark and the remaining 50% vests on March 14, 2028, aligning compensation with multi‑year service.
KURTZ KNUTE P. reported acquisition or exercise transactions in this Form 4 filing.
Veritone, Inc. director Knute P. Kurtz received two equity awards in the form of restricted stock units (RSUs) tied to the company’s common stock. Each grant covers 120,000 shares, for a total of 240,000 underlying shares of Veritone stock.
One 120,000-share RSU grant will fully vest on the earlier of July 7, 2027, or the day immediately before Veritone’s 2027 annual meeting of stockholders. The other 120,000-share grant vests in two equal parts, with 50% on the same 2027 date and the remaining 50% on March 14, 2028. These are compensation-related awards at no purchase price, not open-market share purchases.
Keithley Michael reported acquisition or exercise transactions in this Form 4 filing.
Veritone, Inc. director Michael Keithley reported compensation-related equity grants rather than open-market trades. On July 7, 2026, he received two awards of restricted stock units, each covering 120,000 shares of common stock, for a total of 240,000 RSUs.
One 120,000-unit grant will vest in full on the earlier of July 7, 2027 or the day immediately before Veritone’s 2027 annual meeting of stockholders. The other 120,000-unit grant will vest 50% on that same earlier date and 50% on March 14, 2028. The awards were granted at no cash cost per share and increase his direct equity stake, with one line of the filing showing 300,000 common shares held directly after the transaction.
Taketa Richard H reported acquisition or exercise transactions in this Form 4 filing.
Veritone, Inc. director Richard H. Taketa reported equity awards and updated holdings. He received two grants of restricted stock units (RSUs), each representing 120,000 shares of Veritone common stock at no purchase price. One 120,000-share RSU award will fully vest on the earlier of July 7, 2027 or the day immediately preceding Veritone’s 2027 annual meeting of stockholders. The other 120,000-share RSU award will vest 50% on the same 2027 date and 50% on March 14, 2028. Following these awards, he holds 349,416 shares directly and 70,848 shares indirectly through a family trust as trustee with his spouse.
Veritone, Inc. announced a restructuring plan that includes a significant workforce reduction and cuts to third-party operating costs. The plan is expected to reduce the company’s workforce by at least 25% compared to its employee count as of March 31, 2026.
The restructuring, which began on June 10, 2026 and is expected to be substantially completed by late July 2026, aims to achieve an annualized reduction of up to 30% in operating expenses versus the trailing twelve months ended March 31, 2026. Veritone cannot yet estimate the total charges, which will mainly relate to severance, transition costs, certain contract exit costs and continued employee benefits.
Veritone, Inc. is asking stockholders to vote at its 2026 virtual annual meeting on July 7, 2026 at 10:30 a.m. Pacific Time. Stockholders of record at the close of business on May 19, 2026, when 92,954,401 common shares were outstanding, are entitled to vote.
The proxy seeks approval to elect two Class III directors, ratify CBIZ CPAs P.C. as independent auditor, and approve an advisory vote on executive compensation. Stockholders are also asked to amend the certificate of incorporation to increase authorized common shares, adopt a second amendment and restatement of the 2023 equity incentive plan, and approve CEO strategic equity awards.
In 2025, CEO Ryan Steelberg received $665,000 in salary, a $166,250 bonus and $1.68 million in stock awards, while CFO Michael Zemetra received $428,000 in salary, a $64,200 bonus and $575,850 in stock awards. Both executives participate in performance-based cash and equity incentive programs.
Veritone, Inc. entered into a sales agreement with UBS Securities, Needham & Company, and Craig-Hallum to sell up to $50.0 million of common stock from time to time in an at-the-market equity offering under its existing Form S-3 shelf registration.
The sales agents will use commercially reasonable efforts to execute sales on The Nasdaq Global Market or other trading venues, for a commission of up to 3.0% of the gross sales price, plus reimbursed expenses. Veritone is not obligated to sell any shares, and the agreement can be terminated by either side on ten days’ notice, upon certain adverse events, or by mutual agreement.
Veritone, Inc. is offering common stock in an at-the-market sales program to raise up to $50,000,000 under a Sales Agreement dated May 21, 2026 with UBS Securities LLC, Needham & Company, LLC and Craig-Hallum Capital Group LLC. Sales may occur from time to time on Nasdaq at prevailing market prices; the prospectus cites a May 20, 2026 reference price of $1.96 per share. The Sales Agents may be deemed underwriters and will receive up to 3.0% of gross proceeds as compensation. Net proceeds are intended for working capital and general corporate purposes, with timing and amounts dependent on market conditions and the Company’s discretion.
Veritone, Inc. is soliciting proxies for its 2026 virtual Annual Meeting to be held on July 7, 2026 at 10:30 a.m. Pacific Time. The record date for voting is May 19, 2026. The meeting is online at www.virtualshareholdermeeting.com/VERI2026.
The Proxy Statement asks shareholders to vote on six proposals, including the election of directors, ratification of the independent auditor, an advisory vote on executive compensation, an amendment to increase authorized common shares, an amendment and restatement of the 2023 Equity Incentive Plan, and approval of the CEO Strategic Awards. Key executive compensation disclosures include $665,000 annual base salary for the CEO, a disclosed $40.7 million non-GAAP net loss for 2025 that triggered a $1.1 million minimum bonus pool, and the forfeiture in March 2026 of certain 2025 performance-based RSUs for the CEO and CFO.